The Use of Trastuzumab in Metastatic Breast Cancer

Impact of Different Lines of Palliative Chemotherapy in Patients with Metastatic Breast Cancer

Targeted Treatment Trastuzumab is found to greatly Improve Long Term Survival of HER2 Breast Cancer Patients

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study

The Impact of Neoadjuvant Chemotherapy on Breast Cancer

Cardiotoxic Effect of Adjuvant Subcutaneous versus Intravenous Trastuzumab in HER-2 Positive Breast Cancer

Assessment of The Efficacy of Trastuzumab as Adjuvant Chemotherapy in Correlation with Clinicopathological Features in Patients with Her/2neu Positive Breast Cancer Attending Suez

Study of Outcome of Early Breast Cancer Patients Treated with Different Chemotherapy Protocols

Outcome of Anthracycline versus Taxane Based Regimens on Different Metastatic Sites in Breast Cancer

Factors affecting Adherence to Adjuvant Hormonal Therapy among Women with Breast Cancer